Shinjiro Amano
- Clinical Biochemistry top 0.5%
- Molecular Biology
- Endocrinology, Diabetes and Metabolism top 5%
- Ophthalmology top 2%
- Nephrology top 5%
- Co-authors
- Yosuke InagakiMasayoshi TakeuchiTamami OkamotoSho‐ichi YamagishiZenji MakitaKohachiro KogaRiichiro AbeShigeaki Ohno
- Topics
- Advanced Glycation End Products research (10 papers)Retinal Diseases and Treatments (7 papers)Fibroblast Growth Factor Research (3 papers)
- Journals
- Journal of Biological ChemistryThe FASEB JournalBiochemical and Biophysical Research Communications
- Partner nations
- JapanUnited States
In The Last Decade
Shinjiro Amano
20 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 92
- Clinical Biochemistry 787
- Molecular Biology 478
- Endocrinology, Diabetes and Metabolism 386
- Ophthalmology 282
- Nephrology 190
Countries citing papers authored by Shinjiro Amano
This map shows the geographic impact of Shinjiro Amano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shinjiro Amano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shinjiro Amano more than expected).
Fields of papers citing papers by Shinjiro Amano
This network shows the impact of papers produced by Shinjiro Amano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shinjiro Amano. The network helps show where Shinjiro Amano may publish in the future.
Co-authorship network of co-authors of Shinjiro Amano
This figure shows the co-authorship network connecting the top 25 collaborators of Shinjiro Amano. A scholar is included among the top collaborators of Shinjiro Amano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shinjiro Amano. Shinjiro Amano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 22 | |
| 3 | 6 | |
| 4 | 7 | |
| 5 | 1 | |
| 6 | 70 | |
| 7 | 99 | |
| 8 | 136 | |
| 9 | 83 | |
| 10 | 148 | |
| 11 | 264 | |
| 12 | 36 | |
| 13 | 34 | |
| 14 | 172 | |
| 15 | 47 | |
| 16 | 218 | |
| 17 | 68 | |
| 18 | 24 | |
| 19 | 40 | |
| 20 | 12 |
About Shinjiro Amano
Shinjiro Amano is a scholar working on Clinical Biochemistry, Ophthalmology and Nephrology, having authored 20 papers that have together received 1.5k indexed citations. Recurring topics across this work include Advanced Glycation End Products research (10 papers), Retinal Diseases and Treatments (7 papers) and Fibroblast Growth Factor Research (3 papers). The work is most often cited by research in Clinical Biochemistry (787 citations), Ophthalmology (282 citations) and Nephrology (190 citations). Shinjiro Amano has collaborated with scholars based in Japan and United States. Frequent co-authors include Yosuke Inagaki, Masayoshi Takeuchi, Tamami Okamoto, Sho‐ichi Yamagishi, Zenji Makita, Kohachiro Koga, Sho‐ichi Yamagishi, Riichiro Abe, Shigeaki Ohno and Akihiko Yoshimura. Their work appears in journals such as Journal of Biological Chemistry, The FASEB Journal and Biochemical and Biophysical Research Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.